COMPANY · NIPC 514799633

ALNYPT UNIPESSOAL, LDA

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €436,186,706.81 across 74 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameALNYPT UNIPESSOAL, LDA
NIPC514799633
Registered officeR. TOMÁS FONSECA,TORRES LISBOA - 5ºANDAR, 1600-209 LISBOA
SourceTED (Jornal Oficial da UE), aviso 244136-2025
Record date15 April 2025

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2020 to 2026. The table below gives the same values.2020: €1,258,613.6420202021: €23,858,819.8020212022: €36,258,171.3620222023: €36,272,645.9220232024: €40,793,124.9320242025: €107,684,770.0420252026: €190,060,561.122026€190,060,561.12
Contracted value by year
YearContractsContract value
20202€1,258,613.64
20216€23,858,819.80
202214€36,258,171.36
202312€36,272,645.92
202410€40,793,124.93
202521€107,684,770.04
20269€190,060,561.12
Contracted value by place of performance
NameContractsContract value
Porto40€338,145,056.90
Lisboa29€95,555,705.22
Coimbra4€799,686.41
Largest contracts
SubjectYearContract value
Medicamento Vutrisiran 50 mg/ml Sol inj Ser 0.5 ml SC ao abrigo do CP 2025/1303 dos SPMS2026€156,231,216
Medicamento Vutrisiran 50 mg/ml Sol inj Ser 0.5 ml SC ao abrigo do CP 2025/1303 dos SPMS2025€39,057,804
261Y000035/13559 - VUTRISIRAN 25 MG/ 0,5 ML SOL IN2026€26,038,536
Medicamento patisiran inj. 2mg/ml 10mg/5ml iv2024€20,264,048
1697/2025 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2022/0055 (Medicamentos diversos), 2023/0304 (Medicamentos do grupo 4: sangue), 2023/0305 (Medicamentos do aparelho cardiovascular), 2023/0436 (Medicamentos pa2025€18,382,386.40

Who they competed with

In 828 contracts with a list of competitors, the company took part and was awarded 31 (4%).

Companies with the most procedures in common
CompanyProcedures in common
Novartis Farma - Produtos Farmacêuticos, SA3
Grunenthal, S.A.3
Laboratórios Pfizer, Lda.3
Janssen-Cilag Farmacêutica, Lda.3
Labesfal - Laboratórios Almiro, S.A.3
B.Braun Medical, Unipessoal Lda.3
korangi produtos farmaceuticos3
BDRPHARMA, LDA3
FERRER PORTUGAL, SA2
Sanofi - Produtos Farmacêuticos, Lda2
LABORATÓRIOS ATRAL, S.A.2
Haleon Portugal, Lda.2
TECNIMEDE- SOCIEDADE TECNICO MEDICINAL S.A.2
Farmoz - Sociedade Técnico Medicinal, S.A.2
Logista, Transportes, Transitários e Pharma, Unipessoal, Lda2
LUNDBECK PORTUGAL, LDA2
CICLUM FARMA UNIPESSOAL,LDA2
LADORATORIO EDOL - PROD. FARMACÊUTICOS,S.A2
ViiV Healthcare, Unipessoal Lda2
Biojam, S.A.2
Janssen Farmacêutica Portugal1
B.BRAUN SURGICAL - PROD. HOSP. LDA.1
DAIICHI SANKYO PORTUGAL, LDA.1
Sermail Logistica Integrada, Lda1
ITALFARMACO, PRODUTOS FARMACÊUTICOS LDA.1

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents37 companies and 37 links. The list below gives the same content as text.Novartis Farma… (NIPC 500063524)Novartis Farma…FERRER PORTUGA… (NIPC 500069190)FERRER PORTUGA…Grunenthal, S.… (NIPC 500101965)Grunenthal, S.…Sanofi - Produ… (NIPC 500134960)Sanofi - Produ…LABORATÓRIOS A… (NIPC 500162085)LABORATÓRIOS A…Laboratórios P… (NIPC 500162166)Laboratórios P…Janssen-Cilag … (NIPC 500189412)Janssen-Cilag …Haleon Portuga… (NIPC 500276994)Haleon Portuga…NIPC 500384045 (NIPC 500384045)NIPC 500384045TECNIMEDE- SOC… (NIPC 500626413)TECNIMEDE- SOC…ALNYPT UNIPESSOAL, LDA (NIPC 514799633)ALNYPT UNIPESSOAL, LDA+26 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

25 more links

Investigations that mention it

No published investigation mentions this company by NIPC.